NCCN HIV感染者恶性肿瘤临床指南(2019第1版)解读与实践体会(3)
[2] Branson BM， Handsfield HH， Lampe MA， et al. Revised recommendations for HIV testing of adults， adolescents， and pregnant women in health-care settings[J]. MMWR Recomm Rep 2006， 55(RR-14)： 1-17.
[3] Chiao EY， Dezube BJ， Krown SE， et al. Time for oncologists to opt in for routine opt-out HIV testing[J]？ JAMA， 2010， 304(3)： 334-339.
[4] Torres HA， Mulanovich V. Management of HIV infection in patients with cancer receiving chemotherapy[J]. Clin Infect Dis， 2014， 59(1)： 106-114.
[5] Libois A， Feoli F， Nkuize M， et al. Prolonged antiretroviral therapy is associated with fewer anal high-grade squamous intraepithelial lesions in HIV-positive MSM in a crosssectional study[J]. Sex Transm Infect， 2017， 93(1)： 15-17.
[6] Piketty C， Selinger-Leneman H， Bouvier AM， et al. Incidence of HIV-related anal cancer remains increased despite longterm combined antiretroviral treatment： results from the french hospital database on HIV[J]. J Clin Oncol， 2012， 30(35)： 4360-4366.
[7] Leeds IL， Alturki H， Canner JK， et al. Outcomes of abdominoperineal resection for management of anal cancer in HIV-positive patients： a national case review[J]. World J Surg Oncol， 2016， 14(1)： 208.
[8] Garg M， Lee JY， Kachnic LA， et al. Phase II trials of cetuximab(CX) plus cisplatin (CDDP)， 5-fluorouracil (5-FU) and radiation(RT) in immunocompetent (ECOG 3205) and HIV-positive(AMC045) patients with squamous cell carcinoma of the anal canal (SCAC)： safety and preliminary efficacy results[J]. J Clin Oncol， 2012， 30(15 Suppl)： Abstract 4030., 百拇医药(闾晨涛)
[3] Chiao EY， Dezube BJ， Krown SE， et al. Time for oncologists to opt in for routine opt-out HIV testing[J]？ JAMA， 2010， 304(3)： 334-339.
[4] Torres HA， Mulanovich V. Management of HIV infection in patients with cancer receiving chemotherapy[J]. Clin Infect Dis， 2014， 59(1)： 106-114.
[5] Libois A， Feoli F， Nkuize M， et al. Prolonged antiretroviral therapy is associated with fewer anal high-grade squamous intraepithelial lesions in HIV-positive MSM in a crosssectional study[J]. Sex Transm Infect， 2017， 93(1)： 15-17.
[6] Piketty C， Selinger-Leneman H， Bouvier AM， et al. Incidence of HIV-related anal cancer remains increased despite longterm combined antiretroviral treatment： results from the french hospital database on HIV[J]. J Clin Oncol， 2012， 30(35)： 4360-4366.
[7] Leeds IL， Alturki H， Canner JK， et al. Outcomes of abdominoperineal resection for management of anal cancer in HIV-positive patients： a national case review[J]. World J Surg Oncol， 2016， 14(1)： 208.
[8] Garg M， Lee JY， Kachnic LA， et al. Phase II trials of cetuximab(CX) plus cisplatin (CDDP)， 5-fluorouracil (5-FU) and radiation(RT) in immunocompetent (ECOG 3205) and HIV-positive(AMC045) patients with squamous cell carcinoma of the anal canal (SCAC)： safety and preliminary efficacy results[J]. J Clin Oncol， 2012， 30(15 Suppl)： Abstract 4030., 百拇医药(闾晨涛)